financetom
Business
financetom
/
Business
/
NamSys Reports Higher Fiscal Third-quarter Revenue, Net Income; Joe Prodan Leaves Board
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NamSys Reports Higher Fiscal Third-quarter Revenue, Net Income; Joe Prodan Leaves Board
Oct 3, 2024 1:35 AM

05:21 PM EDT, 09/25/2024 (MT Newswires) -- NamSys ( NMYSF ) said Wednesday that its fiscal third-quarter revenue and profit rose year-over-year.

For the quarter ended July 31, the company earned $581,481, or $0.02 per share, up from $362,049, or $0.01, a year ago. Revenue rose 15% to $1.74 million from $1.52 million a year earlier.

The company also said it bought and canceled an additional 128,200 common shares, bringing the total to 405,000 shares purchased and canceled under the Normal Course Issuer Bid that started on Aug. 30, 2023, and expired this Aug. 30.

Separately, NamSys ( NMYSF ) said Joe Prodan has resigned from the board of directors, effective Sept. 30th. The company added that Michael Robb has joined the board and will be serving on the audit committee.

The company's shares last traded Sept.23, closing at $1.05 on the TSX Venture Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EnGene's Mid-Stage Trial Shows Improved Complete Response Rate in Non-Muscle Invasive Bladder Cancer Patients
EnGene's Mid-Stage Trial Shows Improved Complete Response Rate in Non-Muscle Invasive Bladder Cancer Patients
Nov 11, 2025
08:09 AM EST, 11/11/2025 (MT Newswires) -- EnGene ( ENGN ) said Tuesday that additional preliminary data from the pivotal cohort of its mid-stage trial of detalimogene voraplasmid showed an improved complete response rate of 62% in six months for patients with high-risk, Bacillus Calmette-Guerin unresponsive non-muscle invasive bladder cancer patients with carcinoma in situ. The data also showed low...
Lithia Buys Elite Porsche, Audi Stores In High-End LA Markets
Lithia Buys Elite Porsche, Audi Stores In High-End LA Markets
Nov 11, 2025
Lithia & Driveway, part of Lithia Motors, Inc. ( LAD ) , announced on Tuesday the acquisition of Porsche Beverly Hills and Audi Santa Monica dealerships. Lithia Motors ( LAD ) is the parent entity, while Lithia & Driveway reflects its combined physical dealership network and online retail platform. The addition of these two premium stores is expected to contribute...
1911 Gold Provides High-Grade Intersections from True North Gold Project in Manitoba
1911 Gold Provides High-Grade Intersections from True North Gold Project in Manitoba
Nov 11, 2025
08:09 AM EST, 11/11/2025 (MT Newswires) -- 1911 Gold ( AUMBF ) reported Tuesday the latest high-grade assays from the True North gold project within the Rice Lake property in Manitoba. Highlights from the San Antonio West target include 24.83 grams per tonne (g/t) gold over 2.60 meters, including 46.00 g/t gold over 1.00 meters, including 63.20 g/t gold over...
Kits Eyecare Reports Record Sales Week With Revenue Up 27% to $4.5 Million
Kits Eyecare Reports Record Sales Week With Revenue Up 27% to $4.5 Million
Nov 11, 2025
08:07 AM EST, 11/11/2025 (MT Newswires) -- Kits Eyecare ( KTYCF ) Tuesday announced record-breaking results for the week of Nov. 1 to Nov. 8. Total sales jumped 27% to $4.48 million, with repeat customers contributing 66% of total revenue. The company said 10,000 glasses were ordered, and glasses revenue rose 50%. Marketing spend took up 14.5% of revenue, or...
Copyright 2023-2026 - www.financetom.com All Rights Reserved